Cell type specificity of neurovascular coupling in cerebral cortex

Loading...
Thumbnail Image

Authors

Uhlířová, Hana
Klç, Kvlcm
Tian, Pfeifang
Thunemann, Martin
Desjardins, Michele
Saisan, Payam A.
Sakadžic, Sava
Ness, Torbjrn V
Mateo, Celine
Cheng, Qun

Advisor

Referee

Mark

Journal Title

Journal ISSN

Volume Title

Publisher

eLife Sciences Publications
Altmetrics

Abstract

Identification of the cellular players and molecular messengers that communicate neuronal activity to the vasculature driving cerebral hemodynamics is important for (1) the basic understanding of cerebrovascular regulation and (2) interpretation of functional Magnetic Resonance Imaging (fMRI) signals. Using a combination of optogenetic stimulation and 2-photon imaging in mice, we demonstrate that selective activation of cortical excitation and inhibition elicits distinct vascular responses and identify the vasoconstrictive mechanism as Neuropeptide Y (NPY) acting on Y1 receptors. The latter implies that task-related negative Blood Oxygenation Level Dependent (BOLD) fMRI signals in the cerebral cortex under normal physiological conditions may be mainly driven by the NPY-positive inhibitory neurons. Further, the NPY-Y1 pathway may offer a potential therapeutic target in cerebrovascular disease.
Identification of the cellular players and molecular messengers that communicate neuronal activity to the vasculature driving cerebral hemodynamics is important for (1) the basic understanding of cerebrovascular regulation and (2) interpretation of functional Magnetic Resonance Imaging (fMRI) signals. Using a combination of optogenetic stimulation and 2-photon imaging in mice, we demonstrate that selective activation of cortical excitation and inhibition elicits distinct vascular responses and identify the vasoconstrictive mechanism as Neuropeptide Y (NPY) acting on Y1 receptors. The latter implies that task-related negative Blood Oxygenation Level Dependent (BOLD) fMRI signals in the cerebral cortex under normal physiological conditions may be mainly driven by the NPY-positive inhibitory neurons. Further, the NPY-Y1 pathway may offer a potential therapeutic target in cerebrovascular disease.

Description

Citation

eLife. 2016, vol. 5, issue 1, p. 1-23.
https://elifesciences.org/content/5/e14315

Document type

Peer-reviewed

Document version

Published version

Date of access to the full text

Language of document

en

Study field

Comittee

Date of acceptance

Defence

Result of defence

Endorsement

Review

Supplemented By

Referenced By

Creative Commons license

Except where otherwised noted, this item's license is described as Creative Commons Attribution 4.0 International
Citace PRO